Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased v H 4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment

Leukemia

Volumn 26, Issue 7, 2012, Pages 1647-1653

  Van Maldegem, F ^a   Wormhoudt, T A M ^a   Mulder, M M S ^a   Oud, M E C M ^a   Schilder Tol, E ^a   Musler, A R ^a   Aten, J ^a   Saeed, P ^a   Kersten, M J ^a   Pals, S T ^a   Van Noesel, C J M ^a   Bende, R J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

B cells; B cell lymphoma; immunoglobulin; inflammation; translocations

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; INTEGRIN; INTEGRIN ALPHA4 BETA7; INTERLEUKIN 4; MESSENGER RNA; PROTEIN BCL 10; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CHLAMYDOPHILA PSITTACI; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; MARGINAL ZONE LYMPHOMA; NUCLEOTIDE SEQUENCE; OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; SALIVARY GLAND; SIGNAL TRANSDUCTION; STOP CODON;

EID: 84863778231     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.28     Document Type: Article

References (52)

1. Bende RJ, van Maldegem F, van Noesel CJ. Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas. Haematologica 2009; 94: 1109-1123.
2. Bende RJ, Aarts WM, de Jong D, Pals ST, van Noesel CJ. Among B-cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med 2005; 201: 1229-1241.
3. Hoogeboom R, Bende RJ, van Noesel CJ. MALT lymphoma-derived rheumatoid factors are nonpolyreactive high-affinity antibodies. Blood 2010; 116: 1818-1819.
4. Wotherspoon AC. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575.
5. van Maldegem F, van Dijk R, Wormhoudt TA, Kluin PM, Willemze R, Cerroni L et al. The majority of cutaneous marginal zone B cell lymphomas express class switched immunoglobulins and develop in a T helper type 2 inflammatory environment. Blood 2008; 112: 3355-3361.
6. Beima KM, Miazgowicz MM, Lewis MD, Yan PS, Huang TH, Weinmann AS. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem 2006; 281: 11992-12000.
7. Chanudet E, Ye H, Ferry J, Bacon C, Adam P, Muller-Hermelink H et al. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J Pathol 2008; 217: 420-430.
8. Zhou Y, Ye H, Martin-Subero JI, Gesk S, Hamoudi R, Lu YJ et al. The pattern of genomic gains in salivary gland MALT lymphomas. Haematologica 2007; 92: 921-927.
9. Honma K, Tsuzuki S, Nakagawa M, Karnan S, Aizawa Y, Kim WS et al. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosomes Cancer 2008; 47: 1-7.
10. Novak U, Rinaldi A, Kwee I, Nandula SV, Rancoita PM, Compagno M et al. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood 2009; 113: 4918-4921.
11. Kato M, Sanada M, Kato I, Sato Y, Takita J, Takeuchi K et al. Frequent inactivation of A20 in B-cell lymphomas. Nature 2009; 459: 712-716.
12. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011; 470: 115-119.
13. Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96: 586-594.
14. Yoo C, Ryu MH, Huh J, Park JH, Kang HJ, Ahn HS et al. Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea. Am J Hematol 2007; 82: 821-823.
15. Chanudet E, Zhou Y, Bacon CM, Wotherspoon AC, Muller-Hermelink HK, Adam P et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol 2006; 209: 344-351.
16. Aigelsreiter A, Leitner E, Deutsch AJ, Kessler HH, Stelzl E, Beham-Schmid C et al. Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience. Leuk Res 2008; 32: 1292-1294.
17. Mulder MM, Heddema ER, Pannekoek Y, Faridpooya K, Oud ME, Schilder-Tol E et al. No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from the Netherlands. Leuk Res 2006; 30: 1305-1307.
18. Bahler DW, Szankasi P, Kulkarni S, Tubbs RR, Cook JR, Swerdlow SH. Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa. Mod Pathol 2009; 22: 833-838.
19. Daibata M, Nemoto Y, Togitani K, Fukushima A, Ueno H, Ouchi K et al. Absence of Chlamydia psittaci in ocular adnexal lymphoma from Japanese patients. Br J Haematol 2006; 132: 651-652.
20. Yakushijin Y, Kodama T, Takaoka I, Tanimoto K, Bessho H, Sakai I et al. Absence of chlamydial infection in Japanese patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue. Int J Hematol 2007; 85: 223-230.
21. Rosado MF, Byrne Jr GE, Ding F, Fields KA, Ruiz P, Dubovy SR et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2006; 107: 467-472.
22. Coupland SE, Foss HD, Anagnostopoulos I, Hummel M, Stein H. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa. Invest Ophthalmol Vis Sci 1999; 40: 555-562.
23. Hara Y, Nakamura N, Kuze T, Hashimoto Y, Sasaki Y, Shirakawa A et al. Immunoglobulin heavy chain gene analysis of ocular adnexal extranodal marginal zone B-cell lymphoma. Invest Ophthalmol Vis Sci 2001; 42: 2450-2457.
24. Mannami T, Yoshino T, Oshima K, Takase S, Kondo E, Ohara N et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001; 14: 641-649.
25. Adam P, Haralambieva E, Hartmann M, Mao Z, Ott G, Rosenwald A. Rare occurrence of IgVH gene translocations and restricted IgVH gene repertoire in ocular MALT-type lymphoma. Haematologica 2008; 93: 319-320.
26. Dagklis A, Ponzoni M, Govi S, Cangi MG, Pasini E, Charlotte F et al. Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation. Leukemia 2011; e-pub ahead of print 25 October 2011; doi: 10.1038/leu.2011.276.
27. Jaffe E, Harris NL, Stein H, Vardiman JW. Pathology and Genetics of Tumours of Haematopoietics and Lymphoid Tissues. IARC Press: Lyon, 2001.
28. Heddema ER, Beld MG, de Wever B, Langerak AA, Pannekoek Y, Duim B. Development of an internally controlled real-time PCR assay for detection of Chlamydophila psittaci in the LightCycler 2.0 system. Clin Microbiol Infect 2006; 12: 571-575.
29. Aarts WM, Willemze R, Bende RJ, Meijer CJLM, Pals ST, van Noesel CJM. VH gene analysis of primary cutaneous B-cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching. Blood 1998; 92: 3857-3864.
30. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today 1995; 16: 237-242.
31. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008; 36 (Web Server issue): W503-W508.
32. Lazarovits AI, Mosciki RA, Kurnick JT, Camerini D, Bhan AK, Baird LG et al. Lymphocyte activation antigens: a monoclonal antibody, anti-Act-1 defines a new late lymphocyte activation antigen. J Immunol 1984; 133: 1857-1862.
33. Haralambieva E, Adam P, Ventura R, Katzenberger T, Kalla J, Holler S et al. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large Bcell lymphomas with extranodal presentation. Leukemia 2006; 20: 1300-1303.
34. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 2008; 319: 1676-1679.
35. Chang B, Casali P. The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994; 15: 367-373.
36. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188: 1679-1689.
37. Koelsch K, Zheng NY, Zhang Q, Duty A, Helms C, Mathias MD et al. Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest 2007; 117: 1558-1565.
38. Tian C, Luskin GK, Dischert KM, Higginbotham JN, Shepherd BE, Crowe Jr JE. Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naive and memory B cells. Mol Immunol 2007; 44: 2173-2183.
39. Tsuiji M, Yurasov S, Velinzon K, Thomas S, Nussenzweig MC, Wardemann H. A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med 2006; 203: 393-400.
40. Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity 2007; 26: 205-213.
41. Isnardi I, Ng YS, Srdanovic I, Motaghedi R, Rudchenko S, von Bernuth H et al. IRAK-4-and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 2008; 29: 746-757.
42. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374-1377.
43. Wu YC, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 2010; 116: 1070-1078.
44. Silberstein LE, Jefferies LC, Goldman J, Friedman DF, Moore JS, Nowell PC et al. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood 1991; 78: 2372-2386.
45. Li Y, Spellerberg MB, Stevenson FK, Capra JD, Potter KN. The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. J Mol Biol 1996; 256: 577-589.
46. Cappione AJ, Pugh-Bernard AE, Anolik JH, Sanz I. Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol 2004; 172: 4298-4307.
47. Maemura K, Fukuda M. Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans. J Biol Chem 1992; 267: 24379-24386.
48. Bende RJ, Smit LA, Bossenbroek JG, Aarts WM, Spaargaren M, de Leval L et al. Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells. Am J Pathol 2003; 162: 105-113.
49. Drillenburg P, van der Voort R, Koopman G, Dragosics B, van Krieken JHJM, Kluin PhM et al. Preferential expression of the mucosal homing receptor integrin a4b7 in gastrointestinal non-Hodgkin's lymphomas. Am J Pathol 1996; 150: 919-927.
50. Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large Bcell lymphoma. Nature 2009; 459: 717-721.
51. Honma K, Tsuzuki S, Nakagawa M, Tagawa H, Nakamura S, Morishima Y et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 2009; 114: 2467-2475.
52. Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G et al. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 2009; 206: 981-989.